GMAB vs RVMD

Genmab A/S and Revolution Medicines, Inc., both Healthcare

Revolution Medicines, Inc. is the larger company at $35B against $33B. Over the past year RVMD returned +155% against +75% for GMAB.

Genmab A/S and Revolution Medicines, Inc. compared on valuation multiples, growth, margins and return
FigureGMABRVMD
Last close$50.98$160
Market cap$33B$35B
Trailing P/E33.2n/a
Revenue growth+19%n/a
Operating margin29%n/a
Net margin26%n/a
Free cash flow yield3.5%n/a
Net cash$3.6B net debtn/a
Insiders, 12 monthsn/asold $152M net
1-year return+75%+155%
5-year return+9.6%+383%

Figures from SEC filings and end-of-day closes. Highlighting marks the higher number in each row, nothing more.

Genmab A/S

Revenue of $2.1B in the quarter to Dec 31, 2025, net income $432M.

Revolution Medicines, Inc.

Revenue of $198M in the quarter to Sep 30, 2026, net income null.

Open these two in the interactive comparison to add more names, change the period or see the correlation.